Selvaraja Elumalai | Analytical Chemistry | Innovative Research Award

Published on by Chemistry Awards

Innovative Research Award

Selvaraja Elumalai
Granules Pharmaceuticals, Inc., United States

Selvaraja Elumalai
Affiliation Granules Pharmaceuticals, Inc.
Country United States
Scopus ID 58897590500
Documents 22
Citations 161
h-index 7
Subject Area Analytical Chemistry
Event International Chemistry Scientist Awards
ORCID 0009-0003-1203-9316

The Innovative Research Award recognizes scholarly excellence demonstrated through sustained research productivity, scientific integrity, and meaningful contributions to analytical chemistry. Selvaraja Elumalai has established a research profile characterized by peer-reviewed publications, measurable citation impact, and active engagement in pharmaceutical analytical sciences. His work contributes to analytical method development, validation, and quality-oriented pharmaceutical research, supporting advancements in modern scientific practice.[1]

Abstract

This article presents an overview of Selvaraja Elumalai’s scholarly profile, emphasizing analytical chemistry research, pharmaceutical quality science, and measurable academic impact through publications and citations. It highlights research productivity, professional recognition, and contributions supporting innovation in analytical methodologies while outlining the academic qualifications that support consideration for the Innovative Research Award within the International Chemistry Scientist Awards framework.[1][2]

Keywords

Analytical Chemistry, Pharmaceutical Analysis, Research Innovation, Scientific Publications, Quality Control, Method Validation, Scopus, Research Impact, Innovative Research Award, International Chemistry Scientist Awards.

Introduction

Analytical chemistry plays a central role in pharmaceutical development by ensuring the reliability, safety, and quality of medicinal products. Researchers working in this discipline contribute to analytical method development, validation, regulatory compliance, and laboratory innovation. Selvaraja Elumalai’s scholarly activities reflect continued engagement in these areas through peer-reviewed publications and measurable scientific output.[1]

Research Profile

Affiliated with Granules Pharmaceuticals, Inc., Selvaraja Elumalai has developed an academic record focused on analytical chemistry and pharmaceutical sciences. According to the available Scopus author profile, the researcher has published 22 indexed documents, received 161 citations, and achieved an h-index of 7, demonstrating consistent scholarly engagement within the scientific community.[1]

Research Contributions

  • Development and validation of analytical methodologies.
  • Support for pharmaceutical quality assurance and regulatory compliance.
  • Contribution to peer-reviewed scientific literature.
  • Promotion of analytical best practices within pharmaceutical research.

Publications

The researcher’s publication portfolio consists of scientific articles indexed in Scopus covering analytical chemistry and pharmaceutical applications. These publications collectively demonstrate expertise in laboratory methods, analytical validation, and quality-oriented scientific investigation while contributing to the dissemination of reproducible research findings.[1]

Research Impact

Citation indicators and publication metrics provide quantitative evidence of scholarly visibility. An h-index of 7, supported by 161 citations across 22 indexed publications, reflects sustained academic engagement and indicates that the research has been referenced by the wider scientific community.[1]

Award Suitability

Based on publicly available scholarly indicators, publication record, citation performance, and contributions to analytical chemistry, Selvaraja Elumalai demonstrates qualifications consistent with evaluation criteria commonly applied to research recognition programs. Continued scientific productivity and professional engagement support consideration for the Innovative Research Award within an international academic recognition framework.[1][3]

Conclusion

Selvaraja Elumalai’s documented research achievements, publication history, citation record, and involvement in analytical chemistry demonstrate a well-established academic profile. The available scholarly evidence reflects meaningful scientific contributions that align with the objectives of recognizing innovation, research quality, and professional excellence in chemistry-related disciplines.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Selvaraja Elumalai, Author ID 58897590500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58897590500
  2. ORCID. (n.d.). ORCID record of Selvaraja Elumalai.
    https://orcid.org/0009-0003-1203-9316
  3. Kuril, A. K., Elumalai, S., & Subbappa, P. K. (n.d.). Ion exchange chromatography: A versatile technique for comprehensive characterization of therapeutic proteins and peptides.
    https://www.sciencedirect.com/org/science/article/abs/pii/S1573411025000253
  4. Elumalai, S., Sharma, M., Dantinapalli, V. L. S., Palanisamy, M., & Kuril, A. K. (n.d.). Applications of green chemistry and nanotechnology as a potential solution for sustainability.
    https://www.researchgate.net/publication/388189376

Assoc. Prof. Dr. Sherif Shawky | Analytical Chemistry Award | Best Researcher Award

Published on by Chemistry Awards

Assoc. Prof. Dr. Sherif Shawky | Analytical Chemistry Award | Best Researcher Award

Assoc. Prof. Dr. Sherif Shawky , Misr Univeristy For Science and Technology , Egypt 

Assoc. Prof. Dr. Sherif Shawky is an expert in cell biology, nanobiotechnology, and molecular diagnostics. With a background in pharmacy and biotechnology, he has held faculty and research positions at leading institutions, including the University of Connecticut, Misr University for Science and Technology, and Zewail City of Science and Technology. His work focuses on CRISPR-based assays, nanoparticles, and microfluidic platforms for early disease detection, particularly for cancers, viral infections, and neurodegenerative diseases. Dr. Shawky has been involved in numerous research projects and has contributed significantly to both academia and entrepreneurship. He has been awarded prestigious fellowships, including the Royal Academy of Engineering’s Leaders Innovation Fellowship, and has mentored many students and professionals in the field.

Professional Profile:

Google Scholar 

Summary of Suitability for Award:

Assoc. Prof. Dr. Sherif Shawky is highly suitable for the “Best Researcher Awards” due to his remarkable contributions to the fields of cell biology, nanobiotechnology, and molecular diagnostics. He holds a Ph.D. in Cell Biology and Nanobiotechnology from Erasmus University Rotterdam, Netherlands, and has an extensive background in the development of advanced diagnostic tools, specifically focusing on diseases like Hepatitis C, Alzheimer’s, and various types of cancer. His innovative work in the design and application of nanomaterials, including nanoparticles (such as silica, gold, magnetic, and carbon dots), in biosensors and point-of-care diagnostic devices has had a significant impact on early detection and quantification of biomarkers related to cancer, liver diseases, and neurodegenerative conditions.

🎓Education:

Assoc. Prof. Dr. Sherif  Shawky  earned his Ph.D. in Cell Biology and Nanobiotechnology from Erasmus University Rotterdam, Netherlands . He also holds a Master’s in Biomolecular Sciences from the Free University Amsterdam, specializing in Molecular Cell Biology . He completed his Bachelor of Pharmacy at Misr University for Science and Technology, Egypt. His academic journey has been marked by significant research contributions in the areas of molecular diagnostics, drug delivery, and biosensors, culminating in innovative diagnostic technologies.

🏢Work Experience:

Assoc. Prof. Dr. Sherif  Shawky  has extensive experience as a Research Assistant Professor at the University of Connecticut (UCONN), working on CRISPR-based assays for Alzheimer’s disease diagnosis. He is an Associate Professor of Biochemistry and Entrepreneurship at Misr University for Science and Technology, where he focuses on the development of smart drug delivery systems. His postdoctoral work at Zewail City involved pioneering nanoparticle-based assays for the detection of viral RNA and cancer biomarkers. He is also a Visiting Scholar at Zewail City, where he leads cutting-edge diagnostics projects.

🏅Awards:

Assoc. Prof. Dr. Sherif  Shawky  has received several prestigious awards for his research and entrepreneurial initiatives. He was selected as a Fellow by the Royal Academy of Engineering, where he also secured second place in the final pitch of the Leaders Innovation Fellowship. His entrepreneurial skills were further recognized when he won first place in the final pitch of the Innovate Egypt Program, a joint initiative by VENTUREWELL, USAID, and the National Academy of Science. Shawky’s innovative contributions have also earned him a mentorship role in various incubators and pre-incubators in Egypt, where he guides aspiring entrepreneurs. He has been recognized for his work in disability inclusion and reducing inequalities in healthcare. These honors highlight his excellence in both scientific research and entrepreneurial ventures, showcasing his commitment to advancing health technologies, biosensors, and nanotechnology. Shawky’s multifaceted work continues to have a lasting impact in both academia and industry.

🔬Research Focus:

Assoc. Prof. Dr. Sherif  Shawky research focuses on the development of nanotechnology-based diagnostic tools for early disease detection, particularly for cancers, viral infections, and neurodegenerative diseases. He specializes in CRISPR/Cas technology, nanoparticle synthesis, and microfluidic chip design. His work on integrating nanoparticles with electrochemical, fluorescence, and colorimetric techniques has led to innovative point-of-care devices for viral RNA quantification and cancer biomarkers. His efforts aim to revolutionize diagnostic technologies for clinical applications.

Publication Top Notes:

  1. Direct detection of unamplified hepatitis C virus RNA using unmodified gold nanoparticles
    • Citations: 141
  2. Nucleic acids biosensors based on metal-organic framework (MOF): Paving the way to clinical laboratory diagnosis
    • Citations: 112
  3. Gold aggregating gold: a novel nanoparticle biosensor approach for the direct quantification of hepatitis C virus RNA in clinical samples
    • Citations: 85
  4. A novel HCV electrochemical biosensor based on a polyaniline@Ni-MOF nanocomposite
    • Citations: 77
  5. A novel Ag/Zn bimetallic MOF as a superior sensitive biosensing platform for HCV-RNA electrochemical detection
    • Citations: 56